LOFIEGO MARIA FORTUNATA | Professor page

Lofiego, M.F., Tufano, R., Bello, E., Solmonese, L., Marzani, F., Piazzini, F., et al. (2025). DNA methylation status classifies pleural mesothelioma cells according to their immune profile: implication for precision epigenetic therapy. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 44(1) [10.1186/s13046-025-03310-0]. - view more
Solmonese, L., Lofiego, M.F., Fazio, C., Marzani, F., Piazzini, F., Bello, E., et al. (2025). The Immunomodulatory Activity of Thymosin Alpha 1 on Tumor Cell Lines and Distinct Immune Cell Subsets. ONCOTARGETS AND THERAPY, 18, 995-1012 [10.2147/OTT.S527785]. - view more
Anichini, A., Caruso, F.P., Lagano, V., Noviello, T.M.R., Tufano, R., Nicolini, G., et al. (2025). Integrated multi-omics profiling reveals the role of the DNA methylation landscape in shaping biological heterogeneity and clinical behaviour of metastatic melanoma. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 44(1) [10.1186/s13046-025-03474-9]. - view more
Lofiego, M.F., Tufano, R., Bello, E., Solmonese, L., Marzani, F., Piazzini, F., et al. (2025). Abstract 4841: DNA methylation status classifies pleural mesothelioma cells according to their immune profile: implication for precision epigenetic therapy. In Cancer Research (pp.4841-4841) [10.1158/1538-7445.am2025-4841]. - view more
Lofiego, M.F., Piazzini, F., Caruso, F.P., Marzani, F., Solmonese, L., Bello, E., et al. (2024). Abstract 2632: A new paradigm for brain tumors treatment: Guadecitabine as a fundamental player to improve tumor immune response. In CANCER RESEARCH (pp.2632-2632) [10.1158/1538-7445.am2024-2632]. - view more

All publications